← Scroll for more →
INSMED Inc (INSM)
Pharmaceutical Preparations
Latest Price
$112.58
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
3.33
P/B Ratio
33.85
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 16.14M | $1.72B | 7.36% | +2.98M | 2026-06-30 |
| BlackRock, Inc. | 15.81M | $1.69B | 7.21% | -870.2K | 2026-06-30 |
| JPMorgan Chase & Co | 10.43M | $1.09B | 4.75% | -12.77M | 2026-06-30 |
| Vanguard Portfolio Management LLC | 10.41M | $1.11B | 4.75% | +36.2K | 2026-06-30 |
| Vanguard Capital Management LLC | 9.79M | $1.04B | 4.46% | +148.7K | 2026-06-30 |
| Baker Bros. Advisors LP | 8.80M | $937.0M | 4.01% | +1.38M | 2026-06-30 |
| Capital International Investors | 8.24M | $878.0M | 3.76% | +2.64M | 2026-06-30 |
| Darwin Global Management, Ltd. | 6.43M | $673.0M | 2.93% | -10.37M | 2026-06-30 |
| Ameriprise Financial Inc | 6.18M | $658.0M | 2.82% | +3.12M | 2026-06-30 |
| Orbis Allan Gray Ltd | 6.08M | $647.0M | 2.77% | +4.20M | 2026-06-30 |